System Biosciences, LLC

Doing business as S B I Part of Cellbio Scientific, LLC

UEI
XKFXDBJYL5Y3
CAGE
45MB7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Website
systembio.com
Founded
2006
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$4,900
FY2024 $164,310
FY2023 -$22,350

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

System Biosciences LLC, doing business as SBI, is a minority-owned small business specializing in exosome research, isolation, and analysis technologies. Registered in SAM.gov since 2005, the company is structured as a limited liability company and is classified as an Asian-Pacific American owned, for-profit organization located in East Palo Alto, California. SBI provides advanced scientific products and services focused on exosome research, gene expression systems, and next-generation sequencing technologies that support various federal research and scientific investigation needs.

The company has secured multiple federal contract awards primarily from health-related agencies, including the National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Aging, Food and Drug Administration, and Medical Command. These contracts, ranging from $9,248 to $150,000, have involved specialized services such as exosomal RNA sequencing, custom cDNA in lentivector constructs, exosome surface/membrane protein profiling, small RNA next-generation sequencing, and exosome isolation solutions. Some contracts were set aside for small businesses, demonstrating SBI's commitment to supporting federal procurement objectives. The contracts typically utilize purchase order mechanisms and focus on cutting-edge molecular biology and genomic research services, indicating SBI's expertise in advanced scientific research support for federal agencies.

Quick answers

Is System Biosciences, LLC registered in SAM.gov?

System Biosciences, LLC's SAM.gov registration expired on October 7, 2026.

What is System Biosciences, LLC's CAGE code?

System Biosciences, LLC's CAGE code is 45MB7, and its Unique Entity ID (UEI) is XKFXDBJYL5Y3.

How much has System Biosciences, LLC received in federal contracts?

Federal contracts obligated $137,060 to System Biosciences, LLC in fiscal years 2023 through 2027.

What is System Biosciences, LLC's most recent federal award?

System Biosciences, LLC's most recent federal contract award is Niaaa - exosome RNA sequencing analyses (75N94024P00606), from National Institute of Child Health and Human Development (NIH), on August 26, 2024.

On GovTribe

See System Biosciences, LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe